tiprankstipranks
Trending News
More News >
Guardian Pharmacy Services, Inc. Class A (GRDN)
NYSE:GRDN
US Market

Guardian Pharmacy Services, Inc. Class A (GRDN) Stock Statistics & Valuation Metrics

Compare
9 Followers

Total Valuation

Guardian Pharmacy Services, Inc. Class A has a market cap or net worth of $1.34B. The enterprise value is $1.03B.
Market Cap$1.34B
Enterprise Value$1.03B

Share Statistics

Guardian Pharmacy Services, Inc. Class A has 24,160,393 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding24,160,393
Owned by Insiders73.65%
Owned by Institutions5.38%

Financial Efficiency

Guardian Pharmacy Services, Inc. Class A’s return on equity (ROE) is -0.61 and return on invested capital (ROIC) is -36.63%.
Return on Equity (ROE)-0.61
Return on Assets (ROA)-0.27
Return on Invested Capital (ROIC)-36.63%
Return on Capital Employed (ROCE)-0.36
Revenue Per Employee361.30K
Profits Per Employee-20.89K
Employee Count3,400
Asset Turnover3.83
Inventory Turnover24.27

Valuation Ratios

The current PE Ratio of Guardian Pharmacy Services, Inc. Class A is -14.39. Guardian Pharmacy Services, Inc. Class A’s PEG ratio is -1.24.
PE Ratio-14.39
PS Ratio0.00
PB Ratio0.00
Price to Fair Value8.81
Price to FCF17.30
Price to Operating Cash Flow13.75
PEG Ratio-1.24

Income Statement

In the last 12 months, Guardian Pharmacy Services, Inc. Class A had revenue of 1.23B and earned -87.29M in profits. Earnings per share was -1.41.
Revenue1.23B
Gross Profit244.37M
Operating Income-62.92M
Pretax Income-66.48M
Net Income-87.29M
EBITDA-43.43M
Earnings Per Share (EPS)-1.41

Cash Flow

In the last 12 months, operating cash flow was 37.72M and capital expenditures -15.43M, giving a free cash flow of 22.29M billion.
Operating Cash Flow37.72M
Free Cash Flow22.29M
Free Cash Flow per Share0.92

Dividends & Yields

Guardian Pharmacy Services, Inc. Class A pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.55
52-Week Price Change13.58%
50-Day Moving Average23.10
200-Day Moving Average
Relative Strength Index (RSI)34.54
Average Volume (3m)294.65K

Important Dates

Guardian Pharmacy Services, Inc. Class A upcoming earnings date is Nov 18, 2025, TBA Not Confirmed.
Last Earnings DateMay 12, 2025
Next Earnings DateNov 18, 2025
Ex-Dividend Date

Financial Position

Guardian Pharmacy Services, Inc. Class A as a current ratio of 1.05, with Debt / Equity ratio of 0.00%
Current Ratio1.05
Quick Ratio0.77
Debt to Market Cap0.00
Net Debt to EBITDA-0.59
Interest Coverage Ratio-19.19

Taxes

In the past 12 months, Guardian Pharmacy Services, Inc. Class A has paid 4.56M in taxes.
Income Tax4.56M
Effective Tax Rate-0.07

Enterprise Valuation

Guardian Pharmacy Services, Inc. Class A EV to EBITDA ratio is -29.51, with an EV/FCF ratio of 30.82.
EV to Sales1.04
EV to EBITDA-29.51
EV to Free Cash Flow30.82
EV to Operating Cash Flow22.11

Balance Sheet

Guardian Pharmacy Services, Inc. Class A has $14.00M in cash and marketable securities with $6.67M in debt, giving a net cash position of -$7.33M billion.
Cash & Marketable Securities$14.00M
Total Debt$6.67M
Net Cash-$7.33M
Net Cash Per Share-$0.30
Tangible Book Value Per Share$1.06

Margins

Gross margin is 19.91%, with operating margin of -5.12%, and net profit margin of -7.11%.
Gross Margin19.91%
Operating Margin-5.12%
Pretax Margin-5.41%
Net Profit Margin-7.11%
EBITDA Margin-3.54%
EBIT Margin-5.14%

Analyst Forecast

The average price target for Guardian Pharmacy Services, Inc. Class A is $28.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$28.00
Price Target Upside38.89% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart Score3
AI Score47
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis